- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Medical Virology, 92.2020, 10, S. 2243-2247, doi:10.1002/jmv.26145, ISSN 1096-9071
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2020
- Creator
- URN
-
urn:nbn:de:hebis:30:3-564652
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kohmer, Niko
- Westhaus, Sandra
- Rühl, Cornelia
- Ciesek, Sandra
- Rabenau, Holger
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2020
Other Objects (12)
Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Untersuchung zur Beteiligung von Kindern in hessischen Kindertagesstätten am Infektionsgeschehen während der SARS-CoV-2-Pandemie: Ergebnisse der SAFE-KiDS-Studie
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Untersuchung zur Beteiligung von Kindern in hessischen Kindertagesstätten am Infektionsgeschehen während der SARS-CoV-2-Pandemie: Ergebnisse der SAFE-KiDS-Studie
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Untersuchung zur Beteiligung von Kindern in hessischen Kindertagesstätten am Infektionsgeschehen während der SARS-CoV-2-Pandemie: Ergebnisse der SAFE-KiDS-Studie
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles